Effect of edaravone, a novel free radical scavenger, supplemented to cardioplegia on myocardial function after cardioplegic arrest: in vitro study of isolated rat heart

[1]  L. Becker.  New concepts in reactive oxygen species and cardiovascular reperfusion physiology. , 2004, Cardiovascular research.

[2]  T. Aybek,et al.  Journal of Inflammation BioMed Central , 2006 .

[3]  F. Xiaodong,et al.  The protective effects of high-dose ascorbic acid on myocardium against reperfusion injury during and after cardiopulmonary bypass. , 1994, The Thoracic and cardiovascular surgeon.

[4]  S. Nishimura,et al.  Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. , 1984, Nucleic acids research.

[5]  M. Nakashima,et al.  Inhibitory effect of MCI-186, a free radical scavenger, on cerebral ischemia following rat middle cerebral artery occlusion. , 1998, General pharmacology.

[6]  S J Allen,et al.  Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function. , 1991, Circulation research.

[7]  C. Yutani,et al.  Efficacy of MCI-186, a free-radical scavenger and antioxidant, for resuscitation of nonbeating donor hearts. , 2007, The Journal of thoracic and cardiovascular surgery.

[8]  山脇 理弘.  Protective effect of edaravone against hypoxia-reoxygenation injury in rabbit cardiomyocytes , 2004 .

[9]  M. Weisfeldt,et al.  Direct measurement of free radical generation following reperfusion of ischemic myocardium. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Murota,et al.  Cardioprotective effect of MCI-186 (3-methyl-1-phenyl-2-pyrazolin-5-one) during acute ischemia-reperfusion injury in rats , 1994 .

[11]  V. Mišík,et al.  Detection of alkoxyl and carbon-centered free radicals in coronary sinus blood from patients undergoing elective cardioplegia. , 1993, Free radical biology & medicine.

[12]  D. Sorescu,et al.  Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. , 2002, Congestive heart failure.

[13]  Y. Fukumoto,et al.  Inhibitory effects of edaravone on the production of tumor necrosis factor-α in the isolated heart undergoing ischemia and reperfusion , 2006, Heart and Vessels.

[14]  J. Dunning,et al.  Is blood cardioplegia superior to crystalloid cardioplegia? , 2008, Interactive cardiovascular and thoracic surgery.

[15]  A. Nicolosi,et al.  Quantitative effects of myocardial edema on the left ventricular pressure-volume relation. Influence of cardioplegia osmolarity over two hours of ischemic arrest. , 1993, The Journal of thoracic and cardiovascular surgery.

[16]  M. Yacoub,et al.  Enhanced efficiency of superoxide dismutase-induced cardioprotection by retrograde intracoronary administration. , 2006, Cardiovascular research.

[17]  R. Weisel,et al.  Effect of orally administered alpha-tocopheryl acetate on human myocardial alpha-tocopherol levels , 1991, Cardiovascular Drugs and Therapy.

[18]  K. Fung,et al.  Myocardial protection of MCI-186 in rabbit ischemia-reperfusion. , 2002, Life sciences.

[19]  H. Ochi,et al.  Quantitative immunohistochemical determination of 8-hydroxy-2'-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[20]  M. Komeda,et al.  Prevention of myocardial reperfusion injury by poly(ADP-ribose) synthetase inhibitor, 3-aminobenzamide, in cardioplegic solution: in vitro study of isolated rat heart model. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[21]  T. Vanden Hoek,et al.  Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. , 2000, Circulation research.

[22]  M. Weisfeldt,et al.  Direct measurement of free radical generation following reperfusion of ischemic myocardium , 1987 .

[23]  Y. Kumagai,et al.  A Pharmacokinetic Study of MCI-186, a Novel Drug for Cerebrovascular Disease in Elderly and Young Healthy Subjects , 1997 .

[24]  A. Shohtsu,et al.  Effect of MCI-186 on postischemic reperfusion injury in isolated rat heart. , 1996, Free radical research.

[25]  T. Watanabe,et al.  Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. , 1994, The Journal of pharmacology and experimental therapeutics.

[26]  M. Komeda,et al.  Spaciotemporal Alteration of 8-hydroxy-2′-deoxyguanosine Levels in Cardiomyocytes After Myocardial Infarction in Rats , 2002, Free radical research.

[27]  I. Blasig,et al.  Inverse relationship between ESR spin trapping of oxyradicals and degree of functional recovery during myocardial reperfusion in isolated working rat heart. , 1990, Cardiovascular research.

[28]  H. Yagi,et al.  Edaravone Prevented Deteriorated Cardiac Function After Myocardial Ischemia-Reperfusion via Inhibiting Lipid Peroxidation in Rat , 2005, Journal of Cardiovascular Pharmacology.

[29]  T. Vanden Hoek,et al.  Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. , 1997, Journal of molecular and cellular cardiology.

[30]  S. Toyokuni.  Reactive oxygen species‐induced molecular damage and its application in pathology , 1999, Pathology international.

[31]  F. Kajiya,et al.  Edaravone preserves coronary microvascular endothelial function after ischemia/reperfusion on the beating canine heart in vivo. , 2007, Journal of pharmacological sciences.

[32]  P. Pagliaro,et al.  Post–conditioning induced cardioprotection requires signaling through a redox–sensitive mechanism, mitochondrial ATP–sensitive K+ channel and protein kinase C activation , 2006, Basic Research in Cardiology.

[33]  J. Dyck,et al.  Intracellular Action of Matrix Metalloproteinase-2 Accounts for Acute Myocardial Ischemia and Reperfusion Injury , 2002, Circulation.

[34]  M. Hori,et al.  Exercise Provides Direct Biphasic Cardioprotection via Manganese Superoxide Dismutase Activation , 1999, The Journal of experimental medicine.

[35]  M. Shimoyama,et al.  Protective effect of edaravone against hypoxia–reoxygenation injury in rabbit cardiomyocytes , 2004, British journal of pharmacology.

[36]  M. Komeda,et al.  Taurine prevents myocardial ischemia/reperfusion-induced oxidative stress and apoptosis in prolonged hypothermic rat heart preservation , 2005, Heart and Vessels.

[37]  N. Dhalla,et al.  Status of myocardial antioxidants in ischemia-reperfusion injury. , 2000, Cardiovascular research.

[38]  R. Jennings,et al.  Evidence against the "early protection-delayed death" hypothesis of superoxide dismutase therapy in experimental myocardial infarction. Polyethylene glycol-superoxide dismutase plus catalase does not limit myocardial infarct size in dogs. , 1990, Circulation research.

[39]  N. Dhalla,et al.  Alterations in cardiac contractile proteins due to oxygen free radicals. , 1991, Biochimica et biophysica acta.